Dr. Philip Worthington Carrott

Doctor Overview

Dr. Philip W. Carrott is a chest and lung surgeon at UVA Health in Charlottesville, Virginia. He also serves as Associate Professor of Surgery and Surgical Director of the Lung Transplant Program. Among other locations, he treats patients at the UVA’s Emily Couric Clinical Cancer Center.

Dr. Carrott’s specialties include thoracic conditions like lung cancer, pleural mesothelioma and esophageal cancer. He is skilled at using minimally invasive surgical techniques. These are often easier on patients with milder side effects and recoveries. Outside of his surgical work, he is also involved in research.

Dr. Carrott has co-authored more than 30 peer-reviewed articles. These primarily focus on minimally invasive methods, general surgery protocols and techniques to improve outcomes. Some of his research has studied surgical methods for pleural mesothelioma. Dr. Carrot may be able to connect patients with clinical trials that are a good fit for them.

Doctor Fast Facts

Main Specialty: Thoracic Surgery

Other Interests & Specialties: Chest wall tumors, esophageal cancer, hiatal hernia, lung transplantation, non-small cell lung carcinoma, paraesophageal hernias, pleurectomy/decortication, rib fractures and video-assisted thoracic surgery (VATS).

Certifications, Awards & Accolades: American Board of Surgery Certification in Surgery, American Board of Thoracic Surgery Certification in Thoracic and Cardiac Surgery

Education & Experience:

• Medical Degree from the University of Kansas School of Medicine
• Residency in Surgery at the Warren Alpert Medical School of Brown University
• Fellowship in Thoracic Surgery at the University of Virginia School of Medicine

Publications

Diagnostic laparoscopy improves staging of malignant pleural mesothelioma with routine positron emission tomography imaging. Ann Thorac Surg. 2021 Nov;112(5):1568–74.

Commentary: Focused attention on proactive identification of deep venous thrombosis after pleurectomy/decortication for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2020 Oct;160(4):1075–6.

Commentary: Usurping the king: A step toward planning a biological checkmate on non-small cell lung carcinoma. J Thorac Cardiovasc Surg. 2019 Sept;158(3):922–3.

Gender disparity in referral for definitive care of malignant pleural effusions. J Surg Res. 2019 Dec;244:409–16.